Development of an additive model to study the significance of heat-labile and hea

开发加性模型来研究热不稳定和热的重要性

基本信息

  • 批准号:
    7235838
  • 负责人:
  • 金额:
    $ 7.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Enterotoxigenic Escherichia coli (ETEC) associated diarrheal disease are responsible for an estimated 400,000 to 800,000 deaths annually. Bacterial adhesins or colonization factors (CFAs) and enterotoxins are the key virulence factors in ETEC diarrhea. Enterotoxins, heat-labile toxin(LT) and heat stable toxins (STa, STb) are the main enterotoxins produced by ETEC, these toxins cause disruption of fluid homeostasis and stimulate fluid secretion, which results in diarrhea. However, very limited studies have been done to study virulence significance of individual enterotoxin and to identify enterotoxin(s) of virulence determinant in ETEC diarrhea, which might directly lag vaccine development using enterotoxin(s) as antigens to prevent or decrease the severity of diarrheal disease in humans. The major obstacle to study the pathogenicity of enterotoxins is the lack of a suitable challenge model. Human subject challenge studies have been very limited because of concerns of safety risk, ethnics, and financial expanses; while rodents, the preferred models of most infectious disease research, show no susceptibility to ETEC, and therefore have little value to study ETEC disease. In contrast, certain pigs are naturally susceptible to ETEC, and K88 fimbrial ETEC pathogens to which pigs are susceptible have been studied most extensively and their correlative relationships with diarrhea are best characterized. This research proposes to clone estAB, estA, and estB genes separately for expression of LT, STa and STb, and to construct model pathogens which will allow us to examine significance of each individual enterotoxin in diarrhea. The overall goal of this project is to develop a versatile model to examine the biological relevance of individual enterotoxin in diarrhea disease. The study will elucidate the roles of LT, STa and STb in ETEC diarrhea, and determine the key enterotoxins that may pave the way for development of human ETEC vaccines based on enterotoxins as antigens.
描述(由申请人提供):产肠毒素大肠杆菌(ETEC)相关腹泻疾病每年导致约40万至80万人死亡。细菌粘附素或定植因子(CFAs)和肠毒素是ETEC腹泻的关键毒力因子。肠毒素,热不稳定毒素(LT)和热稳定毒素(STa, STb)是ETEC产生的主要肠毒素,这些毒素会破坏体液平衡并刺激体液分泌,从而导致腹泻。然而,在研究个体肠毒素的毒力意义和鉴定肠毒素在ETEC腹泻中的毒力决定因素方面的研究非常有限,这可能直接滞后于利用肠毒素作为抗原来预防或降低人类腹泻疾病严重程度的疫苗开发。研究肠道毒素致病性的主要障碍是缺乏合适的攻毒模型。由于安全风险、伦理和财政扩张的考虑,人体挑战研究非常有限;而啮齿类动物作为大多数传染病研究的首选模型,对ETEC没有易感性,因此对ETEC疾病的研究价值不大。相反,某些猪对ETEC自然易感,而猪易感的K88毛状ETEC病原体被研究得最广泛,其与腹泻的相关性也得到了最好的表征。本研究拟分别克隆表达LT、STa和STb的estAB、estA和estB基因,并构建模型病原体,以检验每种肠毒素在腹泻中的意义。该项目的总体目标是建立一个通用模型,以检查个体肠毒素在腹泻疾病中的生物学相关性。该研究将阐明LT、STa和STb在ETEC腹泻中的作用,并确定关键的肠毒素,为开发以肠毒素为抗原的人ETEC疫苗铺平道路。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WEIPING ZHANG其他文献

WEIPING ZHANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WEIPING ZHANG', 18)}}的其他基金

Development of MecVax, a Cross Protective Subunit Vaccine for ETEC
开发 ETEC 交叉保护亚单位疫苗 MecVax
  • 批准号:
    10704838
  • 财政年份:
    2023
  • 资助金额:
    $ 7.18万
  • 项目类别:
A broadly protective subunit vaccine against enterotoxigenic Escherichia coli (ETEC) associated diarrhea
一种针对产肠毒素大肠杆菌 (ETEC) 相关腹泻的广泛保护性亚单位疫苗
  • 批准号:
    9280788
  • 财政年份:
    2016
  • 资助金额:
    $ 7.18万
  • 项目类别:
A broadly protective subunit vaccine against enterotoxigenic Escherichia coli (ETEC) associateddiarrhea
一种针对产肠毒素大肠杆菌 (ETEC) 相关腹泻的广泛保护性亚单位疫苗
  • 批准号:
    9912501
  • 财政年份:
    2016
  • 资助金额:
    $ 7.18万
  • 项目类别:
A broadly protective subunit vaccine against enterotoxigenic Escherichia coli (ETEC) associated diarrhea
一种针对产肠毒素大肠杆菌 (ETEC) 相关腹泻的广泛保护性亚单位疫苗
  • 批准号:
    9174335
  • 财政年份:
    2016
  • 资助金额:
    $ 7.18万
  • 项目类别:
A broadly protective subunit vaccine against enterotoxigenic Escherichia coli (ETEC) associateddiarrhea
一种针对产肠毒素大肠杆菌 (ETEC) 相关腹泻的广泛保护性亚单位疫苗
  • 批准号:
    9922200
  • 财政年份:
    2016
  • 资助金额:
    $ 7.18万
  • 项目类别:
A subunit vaccine for enterotoxigenic E. coli associated traveler's diarrhea
一种针对产肠毒素大肠杆菌相关旅行者腹泻的亚单位疫苗
  • 批准号:
    8700107
  • 财政年份:
    2014
  • 资助金额:
    $ 7.18万
  • 项目类别:
A subunit vaccine for enterotoxigenic E. coli associated traveler's diarrhea
一种针对产肠毒素大肠杆菌相关旅行者腹泻的亚单位疫苗
  • 批准号:
    8838707
  • 财政年份:
    2014
  • 资助金额:
    $ 7.18万
  • 项目类别:
Determining vaccine candidacy of LT and STa toxoid fusions against enterotoxigeni
确定针对肠毒素的 LT 和 STa 类毒素融合疫苗的候选资格
  • 批准号:
    7860302
  • 财政年份:
    2009
  • 资助金额:
    $ 7.18万
  • 项目类别:
Determining vaccine candidacy of LT and STa toxoid fusions against enterotoxigeni
确定针对肠毒素的 LT 和 STa 类毒素融合疫苗的候选资格
  • 批准号:
    7706959
  • 财政年份:
    2009
  • 资助金额:
    $ 7.18万
  • 项目类别:
Pathogenesis of EAST1 toxin in ETEC associated diarrhea disease
EAST1 毒素在 ETEC 相关腹泻病中的发病机制
  • 批准号:
    7363893
  • 财政年份:
    2008
  • 资助金额:
    $ 7.18万
  • 项目类别:

相似海外基金

Development of a Drosophila-based platform to replace and reduce animal experimentation in epilepsy research
开发基于果蝇的平台来取代和减少癫痫研究中的动物实验
  • 批准号:
    NC/V001051/1
  • 财政年份:
    2020
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Research Grant
Doctoral Dissertation Research: Ethical Issues in Animal Experimentation
博士论文研究:动物实验的伦理问题
  • 批准号:
    1424484
  • 财政年份:
    2014
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Standard Grant
Animal Experimentation Core
动物实验核心
  • 批准号:
    7665015
  • 财政年份:
    2008
  • 资助金额:
    $ 7.18万
  • 项目类别:
Core--Animal Experimentation
核心——动物实验
  • 批准号:
    7422298
  • 财政年份:
    2007
  • 资助金额:
    $ 7.18万
  • 项目类别:
Animal Experimentation Core
动物实验核心
  • 批准号:
    7502321
  • 财政年份:
    2007
  • 资助金额:
    $ 7.18万
  • 项目类别:
Tissue formation involving stem/progenitor cell research and animal experimentation (N01)
涉及干/祖细胞研究和动物实验的组织形成(N01)
  • 批准号:
    30245585
  • 财政年份:
    2006
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Collaborative Research Centres
Core--Animal Experimentation
核心——动物实验
  • 批准号:
    7312565
  • 财政年份:
    2006
  • 资助金额:
    $ 7.18万
  • 项目类别:
Animal Experimentation system as an infrastructure to support translational progression of diabetes research to medical practice
动物实验系统作为支持糖尿病研究向医学实践转化的基础设施
  • 批准号:
    17200029
  • 财政年份:
    2005
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Animal experimentation and cardiac phenotyping of transgenic mouse models
转基因小鼠模型的动物实验和心脏表型分析
  • 批准号:
    13327687
  • 财政年份:
    2005
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Research Units
Core--Animal Experimentation
核心——动物实验
  • 批准号:
    6892955
  • 财政年份:
    2005
  • 资助金额:
    $ 7.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了